US-based dentistry-focused medical device manufacturer Sonendo raised $35m in funding on Monday in a round including CVF, an investment affiliate of conglomerate Henry Crown and Company.
Dinova Capital also took part in the round, alongside existing backers Fjord Ventures, Orbimed Advisors, Meritech Capital Partners, Neomed Management and SEB Private Equity.
Those investors, along with Themes Investment Partners and Oxford Finance, had previously supplied a total of approximately $108m in equity and debt for Sonendo, according to regulatory filings.
Founded in 2006, Sorendo is working on medical devices for dentistry. Its lead product, GentleWave System, uses a combination of cleaning fluids and acoustic waves to clean teeth during a root canal procedure.
The funding will go toward commercialisation of GentleWave as well as the development of additional products that exploit the same underlying technology, dubbed multisonic ultracleaning. Michael Zhao of Dinova Capital has joined Sonendo’s board of directors as part of the deal.
Bjarne Bergheim, president and chief executive of Sonendo, said: “With Dinova Capital and CVF, we are pleased to expand our top-tier syndicate of committed, long-term investors who recognise the significant potential of this breakthrough technology.”